The NPM1 and FLT3 test is a specialized genetic test conducted to detect mutations in the NPM1 and FLT3 genes, which are often associated with acute myeloid leukemia (AML). This test is crucial for the diagnosis, prognosis, and determination of treatment strategies for patients with AML. The NPM1 gene mutation generally indicates a better response to certain treatments and a more favorable prognosis, whereas FLT3 mutations, particularly the internal tandem duplications (ITD), are associated with a higher risk of relapse and a poorer prognosis.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to identify any mutations in these genes. The process is meticulous and requires specialized equipment and expertise to ensure accurate results. The cost of the NPM1 and FLT3 test at DNA Labs UAE is 2400 AED, reflecting the comprehensive nature of the analysis and the critical insights it provides into the patient's condition. This test is a valuable tool in the personalized treatment planning for AML patients, helping healthcare providers to tailor therapies that offer the best chances of success based on the genetic makeup of the leukemia.
The "PDGFR Mutation Screening Exons 12, 14, 18 Test" is a specialized genetic test offered by DNA Labs UAE, designed to detect mutations in specific exons (12, 14, and 18) of the Platelet-Derived Growth Factor Receptor (PDGFR) gene. Mutations in these regions can be indicative of various medical conditions, including certain types of cancers and gastrointestinal stromal tumors (GISTs). This test is crucial for the precise diagnosis and tailored treatment planning for individuals suspected of having diseases associated with PDGFR mutations. The cost of the test is set at 2400 AED, reflecting the sophisticated technology and expertise required to accurately identify these genetic variations. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test provides valuable insights for healthcare providers, enabling them to make informed decisions regarding patient care and management.
The PDL1 SP263 Clone Test is a diagnostic assay performed at DNA Labs UAE, designed to evaluate the expression of the Programmed Death-Ligand 1 (PD-L1) protein in cancer patients. PD-L1 is a crucial protein involved in the body's immune response to cancer, as it can suppress the immune system and allow cancer cells to grow and spread. The SP263 clone is a specific antibody used in immunohistochemistry (IHC) to detect PD-L1 expression in tumor cells and immune cells within the tumor microenvironment.
This test is particularly important for patients with certain types of cancer, such as non-small cell lung cancer (NSCLC), urothelial carcinoma, and others, as it helps in determining their eligibility for immunotherapy treatments targeting PD-L1. By identifying patients who express PD-L1, clinicians can tailor treatment plans to include therapies that block the PD-L1 pathway, potentially leading to better treatment outcomes.
The cost of the PDL1 SP263 Clone Test at DNA Labs UAE is 2400 AED. This investment in diagnostics is vital for enabling personalized medicine, allowing for treatments that are more specifically aligned with the individual's cancer characteristics. The test is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers in making informed treatment decisions.
The "PNH Comprehensive Work-Up Flowcytometry-Flaer CD14 CD15 CD24 CD45CD59 CD64 GLY-A Test" is an advanced diagnostic assessment offered by DNA Labs UAE, designed to identify and evaluate Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare and life-threatening blood disorder. This test employs flow cytometry technology combined with specific markers—FLAER (Fluorescent Aerolysin), CD14, CD15, CD24, CD45, CD59, CD64, and Glycosylphosphatidylinositol (GPI) anchor (GLY-A)—to detect the absence or reduction of GPI-anchored proteins on the surface of blood cells, which is characteristic of PNH.
The inclusion of FLAER and a comprehensive panel of markers enhances the sensitivity and specificity of the test, allowing for a detailed analysis of different cell populations, including red blood cells, white blood cells, and platelets. This thorough approach aids in the accurate diagnosis of PNH, facilitating appropriate treatment planning and management for affected individuals.
The test is priced at 2400 AED and is performed in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality diagnostic services. By leveraging advanced flow cytometry techniques and expert analysis, DNA Labs UAE provides critical insights into PNH, supporting healthcare providers in delivering targeted care to patients with this complex condition.
Pre-implantation Genetic Screening (PGS) is a cutting-edge genetic test performed on embryos before they are implanted into the uterus during an IVF (In Vitro Fertilization) cycle. This screening aims to analyze embryos for any chromosomal abnormalities, ensuring that only the healthiest embryos are selected for implantation, which can significantly increase the chances of a successful pregnancy and reduce the risk of genetic disorders. DNA Labs UAE offers this sophisticated test at a cost of 2400 AED per embryo. By choosing to have the PGS test done at DNA Labs UAE, prospective parents can gain valuable insights into their embryos' genetic health, aiding in making informed decisions about their family planning journey.
The "Fungal Aspergillus Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a sophisticated diagnostic tool designed to identify and distinguish various strains of Aspergillus fungi, a common pathogen that poses significant health risks, especially to individuals with compromised immune systems. This test employs cutting-edge RNA detection methodologies to accurately and qualitatively assess the presence of different Aspergillus species within a sample.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test offers a rapid and reliable solution for healthcare providers to diagnose Aspergillus infections. This is crucial for implementing timely and appropriate treatment strategies, thereby preventing the progression of the infection and reducing the risk of severe health complications.
The cost of the test is set at 2890 AED, reflecting the advanced technology and expertise involved in conducting this specialized diagnostic procedure. By investing in this test, patients and healthcare providers gain access to vital information that can significantly influence the management and outcome of Aspergillus-related health issues.
The "Fungal Candida Multiplex Detection and Differentiation RNA Detection Qualitative Test" is an advanced diagnostic tool available at DNA Labs UAE, designed to accurately identify and differentiate various Candida species in clinical samples through RNA detection. Priced at 2890 AED, this test employs sophisticated molecular techniques to qualitatively analyze the presence of Candida fungi, which are common pathogens responsible for infections ranging from superficial to systemic candidiasis. The multiplex aspect of the test allows for the simultaneous detection of multiple Candida species, providing critical information for the appropriate clinical management and treatment of infections. This test is particularly valuable in clinical settings where rapid and precise identification of the Candida species can significantly impact patient outcomes.
The Thrombotic Risk Screen Test, offered at DNA Labs UAE for a cost of 2890 AED, is a comprehensive diagnostic tool designed to assess an individual's risk of developing thrombosis. Thrombosis refers to the formation of blood clots within blood vessels, which can lead to serious health complications such as stroke, heart attack, or deep vein thrombosis (DVT). This test analyzes genetic markers, blood clotting factors, and other relevant biomarkers to evaluate a person's predisposition to thrombotic conditions. By identifying individuals at higher risk, the Thrombotic Risk Screen Test enables proactive measures to be taken, such as lifestyle adjustments or medical interventions, to reduce the likelihood of thrombotic events. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a crucial step for those concerned about their thrombotic risk profile, offering peace of mind and the opportunity for preventive care.
Deep Vein Thrombosis (DVT) Panel Test at DNA Labs UAE
The Deep Vein Thrombosis Panel Test is a comprehensive diagnostic assessment offered at DNA Labs UAE, designed to detect the presence of blood clots that form in the deep veins of the body, particularly in the legs. These clots can be life-threatening if they dislodge and travel to the lungs, causing a pulmonary embolism. The DVT Panel Test is crucial for individuals at risk of developing such conditions, including those with a history of clotting disorders, prolonged immobility, recent surgery, or certain genetic predispositions.
This panel test includes a range of assays that evaluate the blood's clotting ability, check for genetic markers associated with clotting disorders, and identify any abnormalities in the coagulation process. It is a vital tool in the prevention, early detection, and management of DVT, helping healthcare providers to tailor the most appropriate treatment plan for their patients.
The cost of the Deep Vein Thrombosis Panel Test at DNA Labs UAE is 3040 AED. Given the critical nature of detecting and managing DVT, this test represents an essential investment in one's health, especially for those with heightened risk factors. DNA Labs UAE is equipped with state-of-the-art facilities and employs cutting-edge technology to ensure accurate and reliable test results, making it a trusted choice for individuals seeking comprehensive health assessments.
The "FISH - Aggressive Lymphoma Panel Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify specific genetic abnormalities associated with aggressive forms of lymphoma. FISH, or Fluorescence In Situ Hybridization, is a molecular cytogenetic technique that allows for the visualization of genetic changes in cells, which are crucial for the diagnosis, prognosis, and treatment planning of lymphoma patients. This test targets genetic markers that are commonly rearranged or mutated in aggressive lymphomas, helping clinicians to classify the subtype of lymphoma more accurately and to tailor treatment strategies accordingly. The cost of the FISH - Aggressive Lymphoma Panel Test at DNA Labs UAE is 3040 AED, reflecting the sophisticated technology and expertise required to perform this detailed analysis.
